Table 2.
Usual Care | QPL Only | QPL+Coach | Total | |
---|---|---|---|---|
M (SD) | M (SD) | M (SD) | M (SD) | |
Observational Measures (n=99) |
||||
Patient Active Participation: Global Rating |
3.30 (.88) | 3.64 (.66) | 3.43 (.77) | 3.45 (.78) |
Patient asked for greater detail |
3.56 (1.08) | 3.84 (.79) | 3.74 (.96) | 3.71 (.95) |
Patient asked for treatment recommendation |
2.60 (.92) | 2.87 (.86) | 2.80 (.96) | 2.75 (.91) |
Patient asked questions | 3.28 (1.15) | 3.84 (.98) | 3.70 (1.05) | 3.59 (1.08) |
Patient offered opinion of treatment |
3.06 (1.07) | 3.40 (.84) | 3.22 (.81) | 3.23 (.93) |
Patient stated preference | 3.25 (1.02) | 3.59 (.84) | 3.13 (.78) | 3.33 (.91) |
Patient expressed concerns | 3.77 (.76) | 4.11 (.62) | 3.93 (.81) | 3.94 (.74) |
Patient expressed opinions | 3.54 (.90) | 3.83 (.71) | 3.53 (.79) | 3.64 (.81) |
Patient Active Participation: (Frequency Count) |
14.42 (12.33) | 20.71 (15.11) | 13.83 (10.57) | 16.40 (13.15) |
Patient information seeking | 11.19 (10.52) | 14.82 (12.63) | 10.90 (9.21) | 12.35 (10.98) |
Patient assertions | 2.83 (3.34) | 5.09 (4.26) | 2.31 (2.24) | 3.45 (3.60) |
Patient expressed concern | .39 (.73) | .79 (1.10) | .62 (1.15) | .60 (1.00) |
Oncologist-Patient Talk Time Ratio |
4.17 (3.47) | 3.27 (1.99) | 3.97 (2.12) | 3.81 (2.67) |
Oncologist Patient-Centered Communication (Observed) |
3.50 (.60) | 3.62 (.49) | 3.64 (.42) | 3.58 (.51) |
Informativeness | 3.76 (.68) | 3.97 (.55) | 4.01 (.53) | 3.90 (.60) |
Supportiveness | 3.50 (.72) | 3.53 (.59) | 3.67 (.46) | 3.56 (.61) |
Partnership building | 3.23 (.54) | 3.35 (.56) | 3.25 (.42) | 3.28 (.51) |
Patient Self-Report Measures |
||||
Oncologist Patient Centeredness (n=107) |
3.65 (.38) | 3.65 (.40) | 3.63 (.31) | 3.64 (.36) |
Patient Role in Treatment Decision (n=85) |
3.07 (1.07) | 3.13 (1.25) | 2.92 (1.09) | 3.05 (1.13) |
Patient Trust in Oncologist (n=97) |
4.08 (.54) | 4.16 (.63) | 4.3 (.67) | 4.20 (.61) |